NEW BRUNSWICK, N.J. -- Booster doses of Johnson & Johnson's one-shot coronavirus vaccine generated a big spike in antibodies, the frontline immune system defenses against infection, the company ...
Johnson & Johnson said Wednesday that new data from early trials of a booster shot of its COVID-19 vaccine provides a "rapid and robust increase in spike-binding antibodies" that fight off the virus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results